Fuller & Thaler Asset Management, Inc. Guardant Health, Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25 Billion
- Q3 2024
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 2,174,717 shares of GH stock, worth $65.7 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,174,717
Previous 1,938,515
12.18%
Holding current value
$65.7 Million
Previous $56 Million
10.93%
% of portfolio
0.2%
Previous 0.24%
Shares
12 transactions
Others Institutions Holding GH
# of Institutions
321Shares Held
127MCall Options Held
651KPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA11.7MShares$354 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$339 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$306 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$209 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$181 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.09B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...